JPRN-UMIN000033634已完成未知
Prospective clinical study on efficacy and tolerability (examination of gastrointestinal symptoms) of mineral and bone disorder of Sucroferric oxyhydroxide in hemodialysis patients - Prospective clinical study on efficacy and tolerability (examination of gastrointestinal symptoms) of mineral and bone disorder of Sucroferric oxyhydroxide in hemodialysis patients
kitasao University, School of Medicine0 个研究点目标入组 10 人开始时间: 2018年8月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who conflict with one of the following are excluded from this study. 1)Patients who have a history of hypersensitivity to the ingredients of sucroferric oxyhydroxide 2)Patients falling under the careful administration of sucroferric oxyhydroxide 3)Patients taking phosphorus binder drugs other than precipitated calcium carbonate 4)Patients taking Lubiprostone 5)Patients receiving antibiotics 6)patients who judged that the doctor in charge is not appropriate
研究者
相似试验
已完成
3 期
Clinical study of the combination of Dexketoprofen and Paracetamol in acute musculoskeletal paiCTRI/2009/091/000114Emcure Pharmaceuticals Limited Pune110
已完成
3 期
Clinical study to evaluate the efficacy and tolerability of FDC of S(+)-Etodolac and Paracetamol Tablet in acute musculoskeletal paiCTRI/2009/091/000720Emcure Pharmaceuticals Ltd, Pune100
进行中（未招募）
不适用
Clinical prospective study to evaluate the efficacy of hygienical therapy and metronidazole in addition to antibiotic therapy in patients affected by bisphosponate-associated osteonecrosis of the jaws - CH.MAX-FACC.02/2009EUCTR2010-019060-37-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
进行中（未招募）
不适用
Estudio clínico para evaluar la eficacia y tolerabilidad de Denutraxan® sobre el alivio del prurito asociado a dermatitis atópica en niños.PruritoEUCTR2010-021568-14-ESISDIN, S.A.
已完成
3 期
Clinical Study to evaluate efficacy and tolerability of Ferric Carboxymaltose InjectioCTRI/2010/091/001203EMCURE PHARMACEUTICALS LIMITED100